475 related articles for article (PubMed ID: 28980714)
21. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
22. Increased basal ganglia binding of
Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
[TBL] [Abstract][Full Text] [Related]
23. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
24. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [
de Vries BM; Timmers T; Wolters EE; Ossenkoppele R; Verfaillie SCJ; Schuit RC; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BNM; Boellaard R; Golla SSV
Mol Imaging Biol; 2021 Aug; 23(4):550-559. PubMed ID: 33443720
[TBL] [Abstract][Full Text] [Related]
26. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
27. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [
Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ
Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672
[TBL] [Abstract][Full Text] [Related]
28. Clinical Utility of
Li L; Liu FT; Li M; Lu JY; Sun YM; Liang X; Bao W; Chen QS; Li XY; Zhou XY; Guan Y; Wu JJ; Yen TC; Jang MK; Luo JF; Wang J; Zuo C;
Mov Disord; 2021 Oct; 36(10):2314-2323. PubMed ID: 34089275
[TBL] [Abstract][Full Text] [Related]
29. Multimodal neuroimaging relationships in progressive supranuclear palsy.
Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
[TBL] [Abstract][Full Text] [Related]
30. Effect of Off-Target Binding on
Baker SL; Harrison TM; Maass A; La Joie R; Jagust WJ
J Nucl Med; 2019 Oct; 60(10):1444-1451. PubMed ID: 30877180
[TBL] [Abstract][Full Text] [Related]
31. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
[TBL] [Abstract][Full Text] [Related]
32. [
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Ghadery C; Kim J; Lang AE; Houle S; Strafella AP
Brain Struct Funct; 2018 Mar; 223(2):589-595. PubMed ID: 28884232
[TBL] [Abstract][Full Text] [Related]
33. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
[TBL] [Abstract][Full Text] [Related]
34. [
Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
[TBL] [Abstract][Full Text] [Related]
35. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
37. Relationship Between
Josephs KA; Tosakulwong N; Weigand SD; Buciuc M; Lowe VJ; Dickson DW; Whitwell JL
J Nucl Med; 2022 Jun; 63(6):931-935. PubMed ID: 34556525
[TBL] [Abstract][Full Text] [Related]
38. Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis.
Jin J; Su D; Zhang J; Li X; Feng T
J Neurol; 2023 May; 270(5):2451-2467. PubMed ID: 36633672
[TBL] [Abstract][Full Text] [Related]
39. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
[TBL] [Abstract][Full Text] [Related]
40. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
